Skip Nav Destination
Article navigation
Articles|
September 01 1956
Clinical and Pharmacological Effects of Substance BZ-55 in Diabetes: (p-Aminophenylsulfonyl Butylcarbamide)
W R Kirtley, M.D.;
Lilly Laboratory for Clinical Research and Lilly Research Laboratories
Indianapolis, Indiana
Search for other works by this author on:
A S Ridolfo, M.D., Ph.D.;
Lilly Laboratory for Clinical Research and Lilly Research Laboratories
Indianapolis, Indiana
Search for other works by this author on:
M A Root, Ph.D.;
Lilly Laboratory for Clinical Research and Lilly Research Laboratories
Indianapolis, Indiana
Search for other works by this author on:
R C Anderson, D.Sc.
Lilly Laboratory for Clinical Research and Lilly Research Laboratories
Indianapolis, Indiana
Search for other works by this author on:
Diabetes 1956;5(5):351–357
Citation
W R Kirtley, A S Ridolfo, M A Root, R C Anderson; Clinical and Pharmacological Effects of Substance BZ-55 in Diabetes: (p-Aminophenylsulfonyl Butylcarbamide). Diabetes 1 September 1956; 5 (5): 351–357. https://doi.org/10.2337/diab.5.5.351
Download citation file: